UC San Francisco (UCSF) researchers have engineered T cells that only produce a strong anti-cancer cytokine when they come into contact with tumour cells. The immunotherapy successfully treated mice with melanoma and pancreatic cancer without causing any significant side effects, and it presents a promising new approach to combating these and other difficult-to-treat tumours.
About the Author
